Evidence map›Paper›PMID 40107311›Full record

ArticleClinical and molecular hepatology2026

vibraA non-invasive risk stratification tool for hepatitis B-related liver cirrhosis: The Baveno VI-SSM combined model: Editorial on "Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis".

Ruiling He, Bingtian Dong, Xiaolong Qi

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and molecular hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. [Chinese guidelines for clinical diagnosis, treatment, and management of cirrhosis (2025)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Guideline
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Ruiling HeLiver Disease Center of Integrated Traditional Chinese and Western Medicine, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology (Southeast University), Nanjing, Jiangsu, China.
Bingtian DongDepartment of Ultrasound, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Xiaolong QiLiver Disease Center of Integrated Traditional Chinese and Western Medicine, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology (Southeast University), Nanjing, Jiangsu, China.

Funding

China Postdoctoral Science Foundation 2024M750461Health Research Program of Anhui AHWJ2023A30169Key Research and Development Program of Jiangsu Province BE2023767aNational Natural Science Foundation of China 82402413Natural Science Foundation of Jiangsu Province BK20241681Southeast University 3290002303A2Zhongda Hospital of Southeast University 2023YJXYYRCPY03Zhongda Hospital of Southeast University CZXM-GSP-RC119Zhongda Hospital of Southeast University CZXM-GSP-RC125
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Baveno VIBaveno VIIDecompensationLiver cirrhosisSpleen stiffness measurement

Identifiers

PMID40107311
PMCPMC12835746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.